Order custom Harvard Business Case Study Analysis & Solution. Starting just $19
Fern Fort University
Edwards Lifesciences VRIO / VRIN Analysis | Assignment Help
What is VRIO / VRIN Analysis ?
VRIO stands for – Value of the resource, Rareness of the resource, Imitation Risk, and Organizational Competence.
VRIO is a resource focused strategic analysis tool.
To build a sustainable competitive advantage the resources that –casename— needs to be valuable, rare, and difficult to imitate. Secondly the –casename— needs to possess capabilities, organizational structure, and culture to optimize the available resources usage. VRIO analysis can help organizations such as Edwards Lifesciences to do better resource allocation and build a defensible value and supply chain.
Order a Edwards Lifesciences VRIO / VRIN Analysis now
What is a Valuable Resource for Edwards Lifesciences? Defining Valuable in VRIO
A resource or capability is considered valuable for Edwards Lifesciences , if it allows the
Edwards Lifesciences to exploit opportunities or negate threats
emerging out of both the micro business environment and the macro environment. If a resource does not allow Edwards Lifesciences to minimize threats or exploit opportunities, than it doesn't contribute signficantly to building a sustainable competitive advantage for Edwards Lifesciences.
What are Rare Resources for Edwards Lifesciences? Defining Rare in VRIO
In an industry that Edwards Lifesciences operates in, valuable resources are held by number of competitors. So valuable resources themselves don’t provide a sustainable competitive advantage. Edwards Lifesciences require rare resources to compete in the industry. If Edwards Lifesciences don’t have rare resources that are required to succeed in the industry then Edwards Lifesciences won’t be able to compete successfully in the marketplace. Secondly holding rare resources can provide Edwards Lifesciences competitive advantage against players that don’t have those rare resources. HBR Case Study Solution
What is a Inimitable (Difficult to Immitate) Resource for Edwards Lifesciences? Defining Inimitable in VRIO
A valuable and rare resource can provide a competitive advantage to Edwards Lifesciences for certain period of time as all the competitors are going to try to imitate or replicate that resource. A sustained competitive advantage emerges, if the resource is difficult to imitate by the competitors. Edwards Lifesciences can create inmitability by innovating on the product side, reducing pain points on service delivery, and having an effective post sales servicing strategy.
Check out the SWOT analysis of Edwards Lifesciences
What is a Organization for Edwards Lifesciences? Defining Organization in VRIO
Even if the Edwards Lifesciences has all the valuable resources that are both rare and difficult to imitate, it won’t automatically result into a sustainable competitive advantage. The key to build the sustainable competitive advantage is to have organizational capabilities, expertise, and structure to exploit the resources. If Edwards Lifesciences is not organized based on its strengths then it won’t able to exploit all the resources that it possesses.
Resources | Value | Rare | Imitation | Organization | Competitive Advantage |
---|---|---|---|---|---|
Opportunities for Brand Extensions for Edwards Lifesciences products | Yes, new niches are emerging in the market | No, as most of the competitors are also targeting those niches | Yes can be imitated by the competitors | Brand extensions will require higher marketing budget | Temporary Competitive Advantage |
Marketing Expertise within Edwards Lifesciences | Yes, firms are competing based on differentiation in the industry | No, as most of the competitors also have good marketing departments and expertise | Pricing strategies of Edwards Lifesciences are often matched by competitors | Yes, Edwards Lifesciences is leveraging both its inhouse marketing department and external expertise | Temporary Competitive Advantage |
Vision of the Leadership for Next Set of Challenges | Yes | No | Can't be imitated by competitors of Edwards Lifesciences | Not based on information provided in the case | Can Lead to Strong Competitive Advantage |
Customer Community of Edwards Lifesciences | Yes, as customers are co-creating products | Yes, the Edwards Lifesciences has able to build a special relationship with its customers | It is very difficult for Edwards Lifesciences competitors to imitate the culture and community dedication | Going by the data, there is still a lot of upside in building on Edwards Lifesciences customers community ecosystem | Providing Strong Competitive Advantage |
Access to Critical Raw Material for Successful Execution | Yes | Yes, as other competitors have to come to terms with Edwards Lifesciences dominant market position | Can be imitated by competitors | Yes | Providing Sustainable Competitive Advantage |
Track Record of Leadership Team at Edwards Lifesciences | Yes | Yes | Can't be imitated by competitors | Yes | Providing Strong Competitive Advantage |
Pricing Strategies of Edwards Lifesciences | Yes, Edwards Lifesciences has sound pricing strategies | No | Pricing strategies are regularly imitated in the industry | Yes, firm has a pricing analytics engine | It can only provide Edwards Lifesciences with a Temporary Competitive Advantage |
Position among Retailers and Wholesalers – Edwards Lifesciences retail strategy | Yes, Edwards Lifesciences has strong relationship with retailers and wholesalers | Yes, Edwards Lifesciences has dedicated channel partners | Difficult to imitate though not impossible | Yes, over the years company has used it successfully | Sustainable Competitive Advantage |
Alignment of Activities with Edwards Lifesciences Corporate Strategy | Yes | No | Each of the firm has its own strategy | Yes, company has organizational skills to extract the maximum out of it. | Still lots of potential to build on it |
Track Record of Project Execution | Yes, especially in an industry where there are frequent cost overun | Yes, especially in the segment that Edwards Lifesciences operates in | No, none of the competitors so far has able to imitate this expertise | Yes, Edwards Lifesciences is successful at it | Providing Strong Competitive Advantage |
Intellectual Property Rights, Copyrights, and Trademarks | Yes, they are extremely valuable for Edwards Lifesciences to thwart competition | Yes, IPR and other rights are rare and competition of Edwards Lifesciences will find it extremely difficult to copy | Risk of imitation is low but given the margins in the industry disruption chances are high | So far the firm has not utilized the full extent of its IPR & other properties | Providing Strong Competitive Advantage |
Sales Force and Channel Management of Edwards Lifesciences | Yes | No | Can be imitated by competitors | Still there is lot of potential to utilize the excellent sales force | Can provide Edwards Lifesciences sustainable competitive advantage. Potential is certainly there. |
Supply Chain Network Flexibility of Edwards Lifesciences | Yes | Yes | Near competitors also have flexible supply chain and share some of the suppliers | Fully utilized by Edwards Lifesciences organizational structure and capabilities | Keeps the business running |
Distribution and Logistics Costs Competitiveness | Yes, as it helps Edwards Lifesciences in delivering lower costs | No | Can be imitated by competitors of Edwards Lifesciences but it is difficult | Yes | Medium to Long Term Competitive Advantage |
Edwards Lifesciences SWOT Analysis, SWOT Matrix, Weighted SWOT Case Study Solution & Analysis
Books and References
Ahir Gopaldas and Anton Siebert (2022 July August) "What You’re Getting Wrong About Customer Journeys",
Harvard Business Review , 92
Linda A. Hill, Emily Tedards, and Taran Swan (2021) "Drive Innovation with Better Decision-Making", Harvard Business Review 86
Dyer, J. H., & Hatch, N. (2004). Using Supplier Networks to Learn Faster. Sloan Management Review, 45(3), 57–63
Barney, J. B. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17, 99–120
Dyer, J. H., Kale, P., & Singh, H. (2004, July–August). When to ally and when to acquire. Harvard Business Review, 109–115
MBA Admission help, MBA Assignment Help, MBA Case Study Help, Online Analytics Live Classes
Order Now
Previous VRIO / VRIN Analysis
- Mutual of America Life Insurance VRIO / VRIN Analysis
- Great Plains Energy VRIO / VRIN Analysis
- Autodesk VRIO / VRIN Analysis
- EnerSys VRIO / VRIN Analysis
- J.Crew Group VRIO / VRIN Analysis
Next 5 VRIO / VRIN Analysis
- Boston Properties VRIO / VRIN Analysis
- ITT VRIO / VRIN Analysis
- Affiliated Managers Group VRIO / VRIN Analysis
- Tops Holding VRIO / VRIN Analysis
- United Refining VRIO / VRIN Analysis